Uceris Approval History

• FDA approved: Yes (First approved January 14th, 2013)
• Brand name: Uceris
• Generic name: budesonide
• Company: Santarus, Inc.
• Treatment for: Ulcerative Colitis

Uceris (budesonide) is a glucocorticosteroid indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis.

FDA Approval History for Uceris

Date	Article
Jan 15, 2013	Santarus Receives FDA Approval of Uceris (budesonide) for the Induction of Remission in Patients with Active, Mild to Moderate Ulcerative Colitis
Aug 13, 2012	Santarus Announces FDA Extension of Uceris New Drug Application Target Action Date to January 16, 2013
Feb 15, 2012	Santarus Announces FDA Acceptance of Uceris New Drug Application for Induction of Remission of Active Ulcerative Colitis
Dec 20, 2011	Santarus Submits New Drug Application to FDA for Uceris (budesonide) Tablets

See also...

Uceris (budesonide) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.